RT Journal Article
T1 Systemic Minoxidil Accidental Exposure in a Paediatric Population: A Case Series Study of Cutaneous and Systemic Side Effects.
A1 Sánchez-Díaz, Manuel
A1 López-Delgado, David
A1 Montero-Vílchez, Trinidad
A1 Salvador-Rodríguez, Luis
A1 Molina-Leyva, Alejandro
A1 Tercedor-Sánchez, Jesús
A1 Arias-Santiago, Salvador
K1 alopecia
K1 children
K1 hypertrichosis
K1 minoxidil
AB Oral minoxidil is an approved treatment for high blood pressure which is also used as an off-label drug for alopecia. Knowledge about the effects of systemic minoxidil in the paediatric population is limited. A retrospective case series study of paediatric patients with history of systemic minoxidil intake due to contaminated sets of omeprazole was performed to describe side effects of high dose oral minoxidil intake in children. Twenty patients aged between 2 months and 13 years joined the study. They had received high doses of oral minoxidil (mean dose 0.90 mg/kg/day) during a mean time of 38.3 days. Hypertrichosis appeared in 65%, with a mean latency time of 24.31 days. Treatment time was associated with the appearance of hypertrichosis (p
SN 2077-0383
YR 2021
FD 2021-09-20
LK https://hdl.handle.net/10668/26447
UL https://hdl.handle.net/10668/26447
LA en
DS RISalud
RD Apr 4, 2025